TrialThe American journal of medicine2004

Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial.

Khaled Aljabri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.